Abstract
Nonalcoholic fatty liver disease, a potentially fatal obesity-related condition, affects more than 70 million people in the United States. Nurses are well-positioned to impact this genetically influenced disease by is increasing awareness, providing patient education, and advocating for affected persons.
MeSH terms
-
Comorbidity
-
Disease Progression
-
Fatty Liver / epidemiology
-
Fatty Liver / genetics*
-
Fatty Liver / nursing
-
Genetic Predisposition to Disease
-
Genetic Variation
-
Humans
-
Lipase
-
Membrane Proteins
-
Non-alcoholic Fatty Liver Disease
-
Prognosis
Substances
-
Membrane Proteins
-
Lipase
-
adiponutrin, human